201 related articles for article (PubMed ID: 30209800)
41. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management.
Cussons AJ; Stuckey BG; Walsh JP; Burke V; Norman RJ
Clin Endocrinol (Oxf); 2005 Mar; 62(3):289-95. PubMed ID: 15730409
[TBL] [Abstract][Full Text] [Related]
42. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
[TBL] [Abstract][Full Text] [Related]
43. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
44. Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome.
Alzamil H; Aloraini K; AlAgeel R; Ghanim A; Alsaaran R; Alsomali N; Albahlal R; Alnuaim L
Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e323-e329. PubMed ID: 33110648
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis and treatment of polycystic ovary syndrome in adolescents.
Conlon JL; Malcolm S; Monaghan M
JAAPA; 2021 Oct; 34(10):15-22. PubMed ID: 34524161
[TBL] [Abstract][Full Text] [Related]
46. American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis.
Wang FF; Pan JX; Wu Y; Zhu YH; Hardiman PJ; Qu F
J Zhejiang Univ Sci B; 2018 May; 19(5):354-363. PubMed ID: 29732746
[TBL] [Abstract][Full Text] [Related]
47. Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome.
Powers SE; Uliassi NW; Sullivan SD; Tuchman LK; Mehra R; Gomez-Lobo V
J Pediatr Adolesc Gynecol; 2015 Feb; 28(1):43-46. PubMed ID: 25555300
[TBL] [Abstract][Full Text] [Related]
48. [The controversies in the diagnosis of polycystic ovary syndrome].
Katulski K; Czyzyk A; Meczekalski B
Pol Merkur Lekarski; 2012 Jul; 33(193):32-7. PubMed ID: 22993908
[TBL] [Abstract][Full Text] [Related]
49. [Polycystic ovary syndrome: is there a rise in the prevalence?].
Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
[TBL] [Abstract][Full Text] [Related]
50. Polycystic Ovary Syndrome in Adolescents.
Witchel SF; Roumimper H; Oberfield S
Endocrinol Metab Clin North Am; 2016 Jun; 45(2):329-44. PubMed ID: 27241968
[TBL] [Abstract][Full Text] [Related]
51. [The role of leptin in polycystic ovary syndrome].
Marciniak A; Starczewski A
Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
[TBL] [Abstract][Full Text] [Related]
52. [Polycystic ovary syndrome I. Clinical presentation and treatment].
Ovesen PG; Møller N; Greisen S; Ingerslev HJ
Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
[TBL] [Abstract][Full Text] [Related]
53. How to manage an adolescent girl presenting with features of polycystic ovary syndrome (PCOS); an exemplar for adolescent health care in endocrinology.
Mani H; Potdar N; Gleeson H
Clin Endocrinol (Oxf); 2014 Nov; 81(5):652-6. PubMed ID: 24826983
[TBL] [Abstract][Full Text] [Related]
54. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
55. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis of polycystic ovary syndrome].
Belosi C; Giuliani M; Suriano R; Sagnella F; Lanzone A
Minerva Ginecol; 2004 Feb; 56(1):7-13. PubMed ID: 14973406
[TBL] [Abstract][Full Text] [Related]
57. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
58. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
[TBL] [Abstract][Full Text] [Related]
59. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.
Moghetti P; Carmina E; De Leo V; Lanzone A; Orio F; Pasquali R; Toscano V
J Endocrinol Invest; 2015 Sep; 38(9):1025-37. PubMed ID: 25835559
[No Abstract] [Full Text] [Related]
60. The Diagnostic Value of Anti-Müllerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome.
Kocaay P; Siklar Z; Buyukfirat S; Berberoglu M
J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):362-366. PubMed ID: 29462707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
